NRx Pharmaceuticals, Inc. NRXP
3.00
(0.03)
(0.99%)
as of 25 Sep
- Market cap
- $131.2M
- P/E
- 0.0×
Follow NRXP
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | — | — | — | — | 0.00 |
P/S ratio |
— | — | — | — | — | — | — | — | 0.00 |
P/FCF ratio |
— | — | — | — | — | — | — | — | 0.00 |
P/Operating CF |
— | — | — | — | — | — | — | — | (15.62) |
P/B ratio |
— | — | — | — | — | — | — | — | 0.00 |
Price to Tangible BV |
— | — | — | — | — | — | — | — | 0.00 |
EV/Sales |
— | — | — | — | — | — | — | — | 0.00 |
EV/EBITDA |
— | — | — | — | — | — | — | — | 0.00 |
EV/Operating CF |
— | — | — | — | — | — | — | — | (4.63) |
EV/FCF |
— | — | — | — | — | — | — | — | (4.62) |
Quick Ratio |
4.82 | 0.02 | 0.00 | 0.06 | 2.32 | 1.29 | 0.24 | 0.07 | 0.28 |
Current Ratio |
5.76 | 0.05 | 0.11 | 0.06 | 2.74 | 1.66 | 0.36 | 0.15 | 0.31 |
Net Debt/EBITDA |
3.34 | (0.67) | (2.74) | 0.02 | 0.23 | 0.22 | 0.17 | (0.28) | 0.48 |
Debt/Assets |
0.00% | 0.97% | 6.09% | 26.32% | 1.53% | 40.77% | 0.00% | 180.14% | 0.00% |
Debt/Equity |
0.00 | 0.14 | 0.39 | (0.02) | 0.02 | 1.42 | 0.00 | (0.28) | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 |
Operating CF/Net income |
1.29 | (7.16) | (1.94) | 0.04 | 0.11 | 1.00 | 0.72 | 0.42 | 0.49 |
Capex/Depreciation |
— | — | — | (0.11) | (3.50) | (2.50) | (0.60) | 0.00 | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (0.15%) | 1.32% | 8.17% | 267.09% | 3,038.41% | (281.79%) | 1,393.99% | 143.75% | 146.18% | |
| (0.15%) | 0.09% | 0.79% | (295.74%) | (1,956.18%) | (135.81%) | (182.06%) | (458.25%) | (344.70%) | |
ROIC |
0.00% | (11.08%) | (6.41%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(23.69%) | (12.30%) | (73.87%) | 119.76% | (1,678.06%) | (389.36%) | 247.94% | 135.44% | 145.86% |
Average Days of Receivables |
— | — | — | 0.00 | — | — | — | — | 47.97 |
Research and Development Expense of Revenue |
— | — | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 308.33% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1,066.20% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.21 |
Share Based Compensation of Revenue |
— | — | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 18.61% |
Graham Net Nets |
— | — | — | — | — | — | — | — | (0.34) |
Graham Number |
— | — | — | — | — | — | — | — | 4.83 |
Earnings Yield |
— | — | — | — | — | — | — | — | (51.29%) |
Free Cash Flow Yield |
— | — | — | — | — | — | — | — | (24.34%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 |
Operating CF per Share |
(0.01) | (1.81) | (2.85) | (0.66) | (8.04) | (6.04) | (2.86) | (1.00) | (0.66) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.01) | (1.81) | (2.85) | (0.66) | (8.04) | (6.05) | (2.86) | (1.00) | (0.66) |
Cash per Share |
0.05 | 0.04 | 0.00 | 0.54 | 5.88 | 3.05 | 0.61 | 0.14 | 0.36 |
Shareholders Equity per Share |
0.55 | 19.12 | 17.97 | (12.77) | 4.43 | 1.13 | (1.55) | (2.18) | (0.74) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.55 | 19.12 | 17.97 | (12.77) | 4.43 | 1.13 | (1.55) | (2.18) | (0.74) |
Free Cash Flow |
(0.14) | (0.47) | (0.79) | (2.27) | (37.71) | (39.76) | (21.66) | (10.64) | (14.11) |
Working Capital |
0.44 | (0.54) | (0.55) | (43.23) | 20.79 | 10.21 | (12.16) | (18.56) | (19.69) |
Capital Expenditures |
— | — | — | 0.00 | (0.01) | (0.01) | 0.00 | — | — |
Net Current Asset Value |
(64.03) | (65.77) | (27.01) | (43.78) | 20.79 | 7.39 | (12.16) | (23.57) | (20.00) |
EV/EBIT |
— | — | — | — | — | — | — | — | 0.00 |
Capex to Sales |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (2,336.49%) |
Price to Operating Income |
— | — | — | — | — | — | — | — | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.50 | 2.27 |
Cash ROIC |
(2.49%) | (8.30%) | (11.40%) | 5.51% | (77.08%) | (104.65%) | 303.40% | 70.03% | 174.14% |
Accounts Receivable Turnover |
— | — | — | — | — | — | — | — | 2.47 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | — | — | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 575,422.50 | 672,877.50 | 189,435.00 | 0.00 | 0.00 | 3,086.24 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | — | — | 0.00 |
Average Receivables |
— | — | — | — | — | — | — | — | 0.50 |
Average Payables |
0.32 | 0.32 | 0.59 | 1.89 | 3.42 | 2.88 | 3.35 | 4.38 | 4.20 |
Average Assets |
70.18 | 70.18 | 51.44 | 17.51 | 17.84 | 29.27 | 16.57 | 5.48 | 8.30 |
Average Common Equity |
69.51 | 5.00 | 5.00 | (19.39) | (11.48) | 14.11 | (2.16) | (17.48) | (19.58) |
Columns are period end dates